BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 18181985)

  • 1. Infliximab in a patient with refractory mucosal aphthosis.
    Jacobi A; Debus D; Schuler G; Hertl M
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):109-10. PubMed ID: 18181985
    [No Abstract]   [Full Text] [Related]  

  • 2. Off-label use of biologicals in the management of inflammatory oral mucosal disease.
    O'Neill ID
    J Oral Pathol Med; 2008 Nov; 37(10):575-81. PubMed ID: 18764859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Up-date on the use of infliximab in dermatology. Introduction].
    Sánchez-Carazo J
    Actas Dermosifiliogr; 2008 Jul; 99 Suppl 4():1. PubMed ID: 19080984
    [No Abstract]   [Full Text] [Related]  

  • 4. Infliximab and nephrotic syndrome.
    Chin G; Luxton G; Harvey JM
    Nephrol Dial Transplant; 2005 Dec; 20(12):2824-6. PubMed ID: 16204273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Infliximab].
    Herrera E; Habicheyn S
    Actas Dermosifiliogr; 2008 Jul; 99 Suppl 4():7-13. PubMed ID: 19080986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment with infliximab of refractory pyoderma gangrenosum in 2 patients with inflammatory bowel diseases.
    Cocco A; Angelucci E; Viscido A; Caprilli R
    Inflamm Bowel Dis; 2007 Oct; 13(10):1317-9. PubMed ID: 17508417
    [No Abstract]   [Full Text] [Related]  

  • 7. Rapid control of therapy-refractory pemphigus vulgaris by treatment with the tumour necrosis factor-alpha inhibitor infliximab.
    Jacobi A; Shuler G; Hertl M
    Br J Dermatol; 2005 Aug; 153(2):448-9. PubMed ID: 16086769
    [No Abstract]   [Full Text] [Related]  

  • 8. Infliximab-induced pityriasis lichenoides chronica in a patient with psoriasis.
    Newell EL; Jain S; Stephens C; Martland G
    J Eur Acad Dermatol Venereol; 2009 Feb; 23(2):230-1. PubMed ID: 18680531
    [No Abstract]   [Full Text] [Related]  

  • 9. Tumor necrosis factor inhibition as a novel treatment for refractory sarcoidosis.
    Sweiss NJ; Welsch MJ; Curran JJ; Ellman MH
    Arthritis Rheum; 2005 Oct; 53(5):788-91. PubMed ID: 16208666
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of hidradenitis suppurativa with tumour necrosis factor-alpha inhibitors: An update on infliximab.
    Brunasso AM; Massone C
    Acta Derm Venereol; 2011 Jan; 91(1):70-1. PubMed ID: 21103830
    [No Abstract]   [Full Text] [Related]  

  • 11. Infliximab in the management of severe pemphigus vulgaris.
    Pardo J; Mercader P; Mahiques L; Sanchez-Carazo JL; Oliver V; Fortea JM
    Br J Dermatol; 2005 Jul; 153(1):222-3. PubMed ID: 16029365
    [No Abstract]   [Full Text] [Related]  

  • 12. Gastric MALT lymphoma in a patient receiving infliximab for psoriasis.
    Girard C; Guillot B; Bessis D
    Br J Dermatol; 2008 Aug; 159(2):497-8. PubMed ID: 18547313
    [No Abstract]   [Full Text] [Related]  

  • 13. Infliximab-induced acne: report of two cases.
    Bassi E; Poli F; Charachon A; Claudepierre P; Revuz J
    Br J Dermatol; 2007 Feb; 156(2):402-3. PubMed ID: 17223901
    [No Abstract]   [Full Text] [Related]  

  • 14. Infliximab treatment failure in a case of cutaneous Crohn's disease.
    Yang DJ; Hsu S
    J Am Acad Dermatol; 2005 Nov; 53(5):903-4. PubMed ID: 16243156
    [No Abstract]   [Full Text] [Related]  

  • 15. Beneficial and rapid effect of infliximab on the course of toxic epidermal necrolysis.
    Wojtkiewicz A; Wysocki M; Fortuna J; Chrupek M; Matczuk M; Koltan A
    Acta Derm Venereol; 2008; 88(4):420-1. PubMed ID: 18709327
    [No Abstract]   [Full Text] [Related]  

  • 16. Dermatologic manifestations of Crohn disease in children: response to infliximab.
    Kugathasan S; Miranda A; Nocton J; Drolet BA; Raasch C; Binion DG
    J Pediatr Gastroenterol Nutr; 2003 Aug; 37(2):150-4. PubMed ID: 12883301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmune hepatitis associated with infliximab in a patient with palmoplantar pustular psoriaisis.
    Fairhurst DA; Sheehan-Dare R
    Clin Exp Dermatol; 2009 Apr; 34(3):421-2. PubMed ID: 19309375
    [No Abstract]   [Full Text] [Related]  

  • 18. Infliximab-induced lichen planopilaris.
    Fernández-Torres R; Paradela S; Valbuena L; Fonseca E
    Ann Pharmacother; 2010 Sep; 44(9):1501-3. PubMed ID: 20702759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infliximab, as sole or combined therapy, induces rapid clearing of erythrodermic psoriasis.
    Takahashi MD; Castro LG; Romiti R
    Br J Dermatol; 2007 Oct; 157(4):828-31. PubMed ID: 17711530
    [No Abstract]   [Full Text] [Related]  

  • 20. Pityriasis rubra pilaris: failure of combination treatment with acitretin and infliximab.
    Lu R; George SJ; Hsu S
    Dermatol Online J; 2006 May; 12(4):18. PubMed ID: 17083873
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.